
CAS Number64221-86-9
SynonymsN-Formimidoylthienamycin; LMipeneM; imipenam; EINECS 264-734-5; Tienamycin; imipemide; N-Formimidoylthiena; Imipenem (JP14); Imipenen; mk-787; Imipenem; MFCD00864955
Molecular FormulaC12H17O4N3S1
Molecular Weight299.35
Purity98%
Density1.6±0.1 g/cm3
Boiling Point530.2±60.0 °C at 760 mmHg
Melting Point106-111ºC
AppearanceWhite crystalline powder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 64221-86-9 |
| Catalog No. | 2A-9010926 |
| Chinese Name | 亚胺培南 |
| Synonyms | N-Formimidoylthienamycin; LMipeneM; imipenam; EINECS 264-734-5; Tienamycin; imipemide; N-Formimidoylthiena; Imipenem (JP14); Imipenen; mk-787; Imipenem; MFCD00864955 |
| Molecular Formula | C12H17O4N3S1 |
| Molecular Weight | 299.35 |
| Purity | 98 |
| Density | 1.6±0.1 g/cm3 |
| Boiling Point | 530.2±60.0 °C at 760 mmHg |
| Melting Point | 106-111ºC |
| Appearance | White crystalline powder |
| Application | Imipenem (N-formamidothiothiamycin, MK0787) is a stable crystalline derivative of thiampycin and an antibiotic with excellent activity against a wide range of Gram-positive bacteria and Gram-negative |
| HTC | 29419000 |
| MDL Number | MFCD00864955 |
| SMILES | CC(O)C1C(=O)N2C(C(=O)O)=C(SCCN=CN)CC12 |
| InChI | InChI=1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1 |
| InChI Key | ZSKVGTPCRGIANV-ZXFLCMHBSA-N |
| MSDS | msds/10926_1_64221_86_9.pdf |
| Use of | Imipenem (N-Formimidoyl thienamycin, MK0787), a stable crystalline derivative of thienamycin, is an antibiotic and has the excellent activity against a broad range of gram-positive and gram-negative aerobic and anaerobic bacteria. Imipenem (N-Formimidoyl thienamycin, MK0787) can be used for carbapenem-nonsusceptible and P. aeruginosa biofilm infections [1][2][3]. Properties Name imipenem Synonym More Synonyms Imipenem Biological Activity Description Imipenem (N-Formimidoyl thienamycin, MK0787), a stable crystalline derivative of thienamycin, is an antibiotic and has the excellent activity against a broad range of gram-positive and gram-negative aerobic and anaerobic bacteria. Imipenem (N-Formimidoyl thienamycin, MK0787) can be used for carbapenem-nonsusceptible and P. aeruginosa biofilm infections [1][2][3]. Related Catalog Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial References [1]. Johann Motsch, et al. RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections. Clin Infect Dis. 2020 Apr 15;70(9):1799-1808. [2]. F P Tally, et al. In vitro activity of N-formimidoyl thienamycin (MK0787). Antimicrob Agents Chemother. 1980 Oct;18(4):642-4. [3]. Wang Hengzhuang, et al. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother. 2012 May;56(5):2683-90. Chemical & Physical Properties Molecular Formula C12H19N3O5S Exact Mass 299.093964 PSA 148.25000 LogP -2.78 Index of Refraction 1.721 InChIKey ZSKVGTPCRGIANV-ZXFLCMHBSA-N Toxicological Information CHEMICAL IDENTIFICATION RTECS NUMBER : CHEMICAL NAME : 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl) amino)ethyl)thio)-7-oxo-, (5R-(5-alpha,6-alpha(R*)))- CAS REGISTRY NUMBER : 64221-86-9 LAST UPDATED : DATA ITEMS CITED : MOLECULAR FORMULA : C12-H17-N3-O4-S MOLECULAR WEIGHT : HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Gastrointestinal - hypermotility, diarrhea REFERENCE : NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year: 33(Suppl 4),119,1985 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea REFERENCE : NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year: 33(Suppl 4),119,1985 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year: 33(Suppl 4),119,1985 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Gastrointestinal - hypermotility, diarrhea REFERENCE : NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year: 33(Suppl 4),119,1985 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea REFERENCE : NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year: 33(Suppl 4),119,1985 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953- Volume(issue)/page/year: 33(Suppl 4),119,1985 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Parenteral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JANTAJ Journal of Antibiotics. (Japan Antibiotics Research Assoc., 2-20-8 Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan) V.2-5, 1948-52; V.21- 1968- Volume(issue)/page/year: 45,1983,1992 Safety Information Hazard Codes Xi HS Code 29419000 Precursor & DownStream Precursor 4 CAS#:85737-71-9 4-nitrobenzyl (... CAS#:74288-40-7 CAS#:75321-08-3 p-Nitrobenzyl (... CAS#:80166-50-3 N-(N-P-Nitro-Be... DownStream 0 |
| Transport Info | Product Name: Imipenem |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Idarubicin | 58957-92-9 | 2A-9010888 |
| Idarubicin Hydrochloride | 57852-57-0 | 2A-9010889 |
| Idarubicinol | 86189-66-4 | 2A-9010890 |
| Ifosfamide | 3778-73-2 | 2A-9010901 |
| Imatinib mesylate | 220127-57-1 | 2A-9010911 |
| Imipenem and Cilastatin Sodium | 85960-17-4 | 2A-9010927 |
| Imipramine N-oxide | 6829-98-7 | 2A-9010928 |
| Indinavir | 157810-81-6 | 2A-9010941 |
| Indomethacin | 53-86-1 | 2A-9010946 |
| Interferon alfacon-1 | 118390-30-0 | 2A-9010956 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA